Loading…
Mustang Bio, Inc. is projected to decline to $0.6552 by 2027, a -7% move from its current price of $0.7036. MBIO is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $0.6766 | $0.7032 | $0.7308 | -0.06% |
| Jul 14 | $0.6655 | $0.7027 | $0.7421 | -0.12% |
| Jul 15 | $0.657 | $0.7023 | $0.7508 | -0.18% |
| Jul 16 | $0.6498 | $0.7019 | $0.7581 | -0.25% |
| Jul 17 | $0.6435 | $0.7014 | $0.7646 | -0.31% |
| Jul 18 | $0.6379 | $0.701 | $0.7704 | -0.37% |
| Jul 19 | $0.6327 | $0.7006 | $0.7758 | -0.43% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.6327 | $0.7006 | $0.7758 | -0.43% |
| Week 2 | $0.6039 | $0.6976 | $0.8058 | -0.85% |
| Week 3 | $0.5821 | $0.6946 | $0.8288 | -1.28% |
| Week 4 | $0.564 | $0.6916 | $0.8481 | -1.70% |
| Week 5 | $0.5482 | $0.6887 | $0.865 | -2.12% |
| Week 6 | $0.5341 | $0.6857 | $0.8803 | -2.54% |
| Week 7 | $0.5213 | $0.6828 | $0.8942 | -2.96% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Mustang Bio, Inc. is a clinical-stage biopharmaceutical company focused on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases in the United States. The company develops MB-106, a CD20-targeted chimeric antigen receptor (CAR) T cell therapy which is in Phase I clinical trail for non-hodgkin lymphoma, chronic lymphocytic leukemia, and autoimmune diseases; MB-109, a combination MB-101 and MB-108 as a potential treatment for IL13Ra2+ relapsed or refractory glioblastoma and high-grade astrocytoma; MB-101, an IL13Ra2 CAR T cell program completed Phase I for glioblastoma; and MB-108 which is in Phase I for the treatment of herpes simplex virus-1 oncolytic virus C134.
It has a license agreement with city of hope national medical center and nationwide children's hospital. Mustang Bio, Inc. was incorporated in 2015 and is headquartered in Waltham, Massachusetts.
The asset Mustang Bio, Inc. (MBIO) is categorized in Healthcare. It currently trades at $0.6999 with a market cap of $5.3M and holds a rank of 5319. The price and position place it among smaller-cap healthcare names.
A major floor 22.1% below — a decisive break under it would weaken the trend.
The nearest floor, 9.9% below — buyers have tended to step in here.
The nearest ceiling, 13.4% above — a clean break opens room to run.
A major ceiling 40.7% above — clearing it would confirm fresh momentum.
Key MBIO support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MBIO market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.7088 | Sell | $0.7089 | Sell |
| MA 10 | $0.7053 | Sell | $0.7059 | Sell |
| MA 20 | $0.7073 | Sell | $0.7038 | Sell |
| MA 50 | $0.6951 | Buy | $0.7164 | Sell |
| MA 100 | $0.7693 | Sell | $0.7971 | Sell |
| MA 200 | $1.00 | Sell | $1.64 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 50.05 | Neutral |
| Stoch RSI (14) | 41.32 | Neutral |
| CCI (20) | -10.38 | Neutral |
| Williams %R (14) | -51.43 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | 1.59 | Buy |
| Bollinger %B (20,2) | 0.47 | Neutral |
| Stochastic %K (14) | 48.57 | Neutral |
| TRIX (15) | 0.03 | Buy |
| Awesome (5,34) | 0.01 | Buy |
| Ultimate (7,14,28) | 53.77 | Neutral |
| Momentum (10) | 0.03 | Buy |
| Aroon Osc (25) | -20.00 | Sell |
| Hull MA (9) | 0.71 | Sell |
| ADX (14) | 7.89 | Neutral |
| ATR (14) | 0.02 | Info |
The near-term technical picture shows bearish sentiment. RSI14 is 50, with the 50-day simple moving average at $0.7064 and the 200-day simple moving average at $1.05. Key levels include support at $0.598 and resistance at $0.798. The 30-day range runs from $0.5294 to $0.9253, and the annualized volatility is 80%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.598 | $0.7036 | $0.8477 | 0% | Neutral | |
| $0.5016 | $0.6552 | $0.9163 | -7% | Neutral | |
| $0.4687 | $0.6379 | $0.9371 | -9% | Neutral | |
| $0.4077 | $0.5744 | $0.8767 | -18% | Bearish | |
| $0.4401 | $0.6396 | $1.01 | -9% | Neutral | |
| $0.5217 | $0.78 | $1.26 | +11% | Neutral | |
| $0.5638 | $0.8656 | $1.44 | +23% | Bullish | |
| $0.5269 | $0.8298 | $1.41 | +18% | Neutral | |
| $0.4844 | $0.7816 | $1.35 | +11% | Neutral | |
| $0.5015 | $0.8282 | $1.46 | +18% | Neutral | |
| $0.6479 | $1.19 | $2.28 | +70% | Bullish | |
| $0.6749 | $1.50 | $3.20 | +113% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.598 | $0.7036 | $0.8605 | +0.00% |
| August 2026 | $0.5943 | $0.7094 | $0.8754 | +0.83% |
| September 2026 | $0.5518 | $0.6653 | $0.8336 | -6.21% |
| October 2026 | $0.5291 | $0.6435 | $0.8166 | -3.29% |
| November 2026 | $0.539 | $0.6603 | $0.8471 | +2.62% |
| December 2026 | $0.5305 | $0.6544 | $0.8477 | -0.90% |
Click any year to see its month-by-month MBIO forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Mustang Bio, Inc.'s 2026 outlook centres on $0.7036, within a $0.598 to $0.8477 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, MBIO could reach as high as $0.9163, with a base case around $0.6552 and support toward $0.5016 — roughly -7% from $0.7036. A consolidation phase looks the most probable path here.
Expect MBIO to range from $0.4687 to $0.9371 through 2028. The $0.6379 average target implies a -9% move from current prices. That is -3% versus the projected 2027 average. Price action looks broadly range-bound.
The MBIO price prediction for 2029 points to an average of $0.5744 (low $0.4077, high $0.8767) — a potential decline of -18% on today's $0.7036. Expect choppier, lower action through this leg of the cycle.
In 2030, MBIO is projected to trade between $0.4401 and $1.01, averaging $0.6396 — a potential decline of -9% from today's $0.7036. That is up +11% on the projected 2029 average. Price action looks broadly range-bound.
Mustang Bio, Inc.'s 2031 outlook centres on $0.78, within a $0.5217 to $1.26 range. That is up +22% on the projected 2030 average. That marks a +11% change versus current levels. A consolidation phase looks the most probable path here.
By 2032, MBIO could reach as high as $1.44, with a base case around $0.8656 and support toward $0.5638 — roughly +23% from $0.7036. Momentum favours further upside here.
Expect MBIO to range from $0.5269 to $1.41 through 2033. The $0.8298 average target implies a +18% move from current prices. That is -4% versus the projected 2032 average. A consolidation phase looks the most probable path here.
The MBIO price prediction for 2034 points to an average of $0.7816 (low $0.4844, high $1.35) — a potential gain of +11% on today's $0.7036. Price action looks broadly range-bound.
In 2035, MBIO is projected to trade between $0.5015 and $1.46, averaging $0.8282 — a potential gain of +18% from today's $0.7036. That is up +6% on the projected 2034 average. A consolidation phase looks the most probable path here.
Mustang Bio, Inc.'s 2040 outlook centres on $1.19, within a $0.6479 to $2.28 range. That is up +44% on the projected 2035 average. That marks a +70% change versus current levels. Momentum favours further upside here.
By 2050, MBIO could reach as high as $3.20, with a base case around $1.50 and support toward $0.6749 — roughly +113% from $0.7036. Buyers look set to stay in control over this stretch.
Investing $1,000 in MBIO today (≈ 1,421.262081 MBIO) could be worth
$2,131.58
+$1,131.58 (+113%) by 2050 · US Dollar
Based on the average projected MBIO price of $1.5 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MBIOwould be worth at today's price.
$1,000 invested in MBIO on Jul 10, 2025 (≈ 373.134319 MBIO) would be worth
$262.54
-$737.46 (-73.7%) today · 0.26× · US Dollar
Based on a MBIO entry price of $2.68 vs. today's $0.7036.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.703 | $1,000.85 | +0.1% |
| 1 month ago | $0.737 | $954.68 | -4.5% |
| 3 months ago | $0.7 | $1,005.14 | +0.5% |
| 6 months ago | $1.11 | $633.87 | -36.6% |
| 1 year ago | $2.68 | $262.54 | -73.7% |
| All time (5.0y) ago | $2,220 | $0.32 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MBIO forecast.
Our base-case forecast reaches $1.40 around 2050.
Implied market cap at $1.40: $9.42M
The multi-year forecast shows a progression from neutral sentiment in the nearer years toward bullish sentiment in the longer term. In 2030 the average price is projected at $0.6426 with a min of $0.43 and a max of $1.04, and a return of -8.2. In 2040 the average price rises to $1.18 with a max of $2.34 and a return of 68.8, with bullish sentiment.
In 2050 the average is $1.42 with a max of $3.16 and a return of 102.6, continuing bullish sentiment.
Tap a question to reveal the answer.
2030 avg $0.6426; min $0.43; max $1.04; ROI -8.2; sentiment Neutral.
Forecasts show a range of outcomes: 2026 avg $0.6999 with ROI 0; 2029 avg $0.5302 with ROI -24.2; 2040 avg $1.18 with ROI 68.8; 2050 avg $1.42 with ROI 102.6.
The 2050 forecast lists a max of $3.16 with an average of $1.42 and ROI 102.6; sentiment is Bullish.
Current price is $0.6999; market cap is $5.3M; rank is 5319.
2040: avg $1.18; max $2.34; ROI 68.8; sentiment Bullish. 2050: avg $1.42; max $3.16; ROI 102.6; sentiment Bullish.
Mustang Bio, Inc. Community Discussion
0Share your Mustang Bio, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.